PDK1 and cholangiocarcinoma: Interestingly, SIRT3 inhibits the cholangiocarcinoma progression via inhibiting the “Warburg effect” through the HIF-1α/pyruvate dehydrogenase kinase 1 (PDK1)/PDHA1 downstream signaling pathway (57).